FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Divgi TorqTransfer Systems IPO and Mankind Pharma IPO.
Divgi TorqTransfer Systems IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Mankind Pharma IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Divgi TorqTransfer Systems IPO | Mankind Pharma IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Inga Ventures Pvt Ltd Equirus Capital Private Limited |
Kotak Mahindra Capital Company Limited Axis Capital Limited Iifl Securities Ltd Jefferies India Private Limited J.P. Morgan India Private Limited |
Registrar | Link Intime India Private Ltd | Kfin Technologies Limited |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Divgi TorqTransfer Systems IPO is up to ₹412.12 Cr whereas the issue size of the Mankind Pharma IPO is up to ₹4,326.36 Cr. The final issue price of Divgi TorqTransfer Systems IPO is ₹590.00 per share and of Mankind Pharma IPO is ₹1,080.00 per share.
Divgi TorqTransfer Systems IPO | Mankind Pharma IPO | |
---|---|---|
Face Value | ₹5 per share | ₹1 per share |
Issue Price (Lower) | ₹560.00 per share | ₹1,026.00 per share |
Issue Price (Upper) | ₹590.00 per share | ₹1,080.00 per share |
Issue Price (Final) | ₹590.00 per share | ₹1,080.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 25 shares | 13 shares |
Fresh Issue Size | ||
Fresh Issue Size (Amount) | up to ₹180.00 Cr | |
OFS Issue Size | 39,34,243 shares | 4,00,58,844 shares |
OFS Issue Size (Amount) | up to ₹232.12 Cr | up to ₹4,326.36 Cr |
Issue Size Total | 4,00,58,844 shares | |
Issue Size Total (Amount) | up to ₹412.12 Cr | up to ₹4,326.36 Cr |
Divgi TorqTransfer Systems IPO opens on Mar 01, 2023, while Mankind Pharma IPO opens on Apr 25, 2023. The closing date of Divgi TorqTransfer Systems IPO and Mankind Pharma IPO is Mar 03, 2023, and Apr 27, 2023, respectively.
Divgi TorqTransfer Systems IPO | Mankind Pharma IPO | |
---|---|---|
Anchor Bid Date | Feb 28, 2023 | Apr 24, 2023 |
Issue Open | Mar 01, 2023 | Apr 25, 2023 |
Issue Close | Mar 03, 2023 | Apr 27, 2023 |
Basis Of Allotment (Tentative) | Mar 09, 2023 | May 03, 2023 |
Initiation of Refunds (Tentative) | Mar 10, 2023 | May 04, 2023 |
Credit of Share (Tentative) | Mar 13, 2023 | May 05, 2023 |
Listing date (Tentative) | Mar 14, 2023 | May 09, 2023 |
Anchor Lockin End date 1 | Apr 08, 2023 | Jun 02, 2023 |
Anchor Lockin End date 2 | Jun 07, 2023 | Aug 01, 2023 |
Divgi TorqTransfer Systems IPO P/E ratio is 35.16, as compared to Mankind Pharma IPO P/E ratio of 32.5.
Divgi TorqTransfer Systems IPO | Mankind Pharma IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 67.18% | 79.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 76.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 35.16 | 32.5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹1804.39 Cr. | ₹43263.60 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 27.60%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 26.10%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹33.20 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 27.70%% |
In the Divgi TorqTransfer Systems IPO retail investors (RII) are offered 6,98,509 shares while in Mankind Pharma IPO retail investors are offered 6,98,509 shares. Qualified institutional buyers (QIB) are offered 20,95,528 shares in Divgi TorqTransfer Systems IPO and 80,11,769 shares in Mankind Pharma IPO.
Divgi TorqTransfer Systems IPO | Mankind Pharma IPO | |
---|---|---|
Anchor Investor Reserveration | 31,43,290 shares | 1,20,17,652 shares |
Market Maker Reserveration | ||
QIB | 20,95,528 shares | 80,11,769 shares |
NII | 10,47,763 shares | 60,08,827 shares |
RII | 6,98,509 shares | 1,40,20,596 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 38,41,800 shares | 2,80,41,192 shares |
Divgi TorqTransfer Systems IPO subscribed 5.44x in total, whereas Mankind Pharma IPO subscribed 15.32x.
Divgi TorqTransfer Systems IPO | Mankind Pharma IPO | |
---|---|---|
QIB (times) | 7.83x | 49.16x |
NII (times) | 1.40x | 3.80x |
Big NII (times) | 0.89x | 4.99x |
Small NII (times) | 2.41x | 1.41x |
RII (times) | 4.31x | 0.92x |
Employee (times) | ||
Other (times) | ||
Total (times) | 5.44x | 15.32x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|